Deals

The firm has acquired Epic Health Services from Webster Capital, a sale which saw Webster reap a 10x multiple on its original $42m acquisition.

This is the firm's first investment in iCapital, which has previously received funding from Panorama Point Partners and Pivot Investment Partners among others. 

Steep valuations in the mid-market are hitting deal and exit activity.

KKR is close to selling capsule maker Capsugel to Swiss drug maker Lonza for more than $5bn.

The firm has invested capital from Apax IX, the $9 billion vehicle it is raising, to buy out Apax France and majority owner Nordic Capital.

The sale is part of a wider move by the bank to reduce its non-core units.

The European energy specialist is in the market raising its debut fund having previously funded investments on a deal-by-deal basis.

The world's largest-ever gathering of impact investors opened with a call to arms.

Carlyle’s newest operating executive, Michael Silverstein, who has specialised in consumer and retail for almost four decades at The Boston Consulting Group, said investing in the sector was ‘very aggressive’ in 2016.

The sale of its stake in the catering group to fellow UK firm Livingbridge will deliver a 3x return to investors in ECI 9.